SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -5.70%  to  Rs. 5234.80 million from Rs. 5551.40 millions.Profit after Tax for the quarter ended December 2022 saw a decline of -39.73% from Rs. 400.70 millions to Rs. 241.50  millions.Operating Profit reported a sharp decline to 496.80 millions from 680.90 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 5234.80 5551.40 -5.70 16299.00 16115.30 1.14 21840.20 19669.80 11.03
Other Income 66.40 88.80 -25.23 168.50 251.10 -32.90 320.40 243.00 31.85
PBIDT 496.80 680.90 -27.04 1475.80 2382.70 -38.06 2883.20 6161.40 -53.21
Interest 47.00 22.90 105.24 115.90 59.50 94.79 82.90 58.30 42.20
PBDT 449.80 658.00 -31.64 1359.90 2183.90 -37.73 2661.00 6103.10 -56.40
Depreciation 117.30 111.30 5.39 340.30 322.50 5.52 432.60 389.20 11.15
PBT 332.50 546.70 -39.18 1019.60 1861.40 -45.22 2228.40 5713.90 -61.00
TAX 91.00 146.00 -37.67 272.50 482.30 -43.50 571.80 1268.30 -54.92
Deferred Tax -7.30 2.50 -392.00 -4.30 -0.40 975.00 1.70 -187.20 -100.91
PAT 241.50 400.70 -39.73 747.10 1379.10 -45.83 1656.60 4445.60 -62.74
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 9.49 12.27 -22.63 9.05 14.79 -38.76 13.20 31.32 -57.86

IOL Chem & Pharma Share Price

96.98 -0.90 (-0.92%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×